Levitex Foams Ltd - Accounts


Levitex Foams Ltd 10333239 Medical and Orthopaedic Product Developement false 1 September 2018 10333239 2018-09-01 2019-08-31 10333239 2018-08-31 10333239 2019-08-31 10333239 2017-09-01 2018-08-31 10333239 2017-08-31 10333239 2018-08-31 10333239 frs102-bus:FRS102 2018-09-01 2019-08-31 10333239 frs102-bus:PrivateLimitedCompanyLtd 2018-09-01 2019-08-31 10333239 frs102-bus:FullAccounts 2018-09-01 2019-08-31 10333239 frs102-bus:AuditExempt-NoAccountantsReport 2018-09-01 2019-08-31 10333239 frs102-core:CurrentFinancialInstruments 2019-08-31 10333239 frs102-core:CurrentFinancialInstruments 2018-08-31 10333239 frs102-core:ShareCapital 2019-08-31 10333239 frs102-core:ShareCapital 2018-08-31 10333239 frs102-core:RetainedEarningsAccumulatedLosses 2019-08-31 10333239 frs102-core:RetainedEarningsAccumulatedLosses 2018-08-31 10333239 frs102-bus:Director1 2018-09-01 2019-08-31 10333239 frs102-core:CopyrightsPatentsTrademarksServiceOperatingRights 2018-08-31 10333239 frs102-core:CopyrightsPatentsTrademarksServiceOperatingRights 2019-08-31 10333239 frs102-core:CopyrightsPatentsTrademarksServiceOperatingRights 2018-09-01 2019-08-31 10333239 frs102-core:CopyrightsPatentsTrademarksServiceOperatingRights 2018-08-31 xbrli:pure iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares
Registered number
10333239
Levitex Foams Ltd
Unaudited Accounts
for the year ended
31 August 2019
Levitex Foams Ltd
Balance Sheet
as at 31 August 2019
Notes
2019
£
2018
£
Fixed assets
Intangible assets 2 13,500 18,000
13,500 18,000
Current assets
Cash at bank and in hand 118,541 204,560
118,541 204,560
Prepayments and accrued income: 3,486 8,221
Creditors: amounts falling due within one year (0) (1,756)
Net current assets / (liabilities) 122,027 211,025
Total assets less current liabilities 135,527 229,025
Accruals and deferred income (3,000) (3,000)
Total net assets (liabilities) 132,527 226,025
Capital and reserves
Called up share capital 500,100 401,700
Profit and loss account (367,573) (175,675)
Shareholders' funds 132,527 226,025

Levitex Foams Ltd
Balance Sheet
as at 31 August 2019



These accounts have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.

For the year ending 31 August 2019 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Signed on behalf of the board of directors

...............................

Mr J Leinhardt

Director


Approved by the board on 7 May 2020

Company Number: 10333239 (a Private Company Limited by Shares registered in England and Wales)

Registered Office:

193a Ashley Road
Hale
Altrincham
Cheshire
WA15 9SQ
United Kingdom

Levitex Foams Ltd
Notes to the Accounts
for the year ended 31 August 2019

1. Accounting policies

Basis of preparation of financial statements
These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The presentation currency is sterling.
Going concern basis
The accounts have been prepared on the assumption that the company is able to carry on business as a going concern for the foreseeable future.
Tangible fixed assets depreciation policy
Tangible fixed assets are stated at cost less accumulated depreciation and impairment losses. Depreciation is provided, after taking account of any grants receivable, at rates calculated to write off the cost of fixed assets, less the estimated residual value, over their estimated useful lives.
2. Intangible fixed assets
Trademarks Total
Cost £ £
At 1 September 2018 21,023 21,023
At 31 August 2019 21,023 21,023
Amortisation
At 1 September 2018 3,023 3,023
Provided during the period 4,500 4,500
At 31 August 2019 7,523 7,523
Net book value
At 31 August 2019 13,500 13,500
At 31 August 2018 18,000 18,000